# FDA Inspection 1193143 - Biomat USA, Inc. - December 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0afa08f2-a5ea-4f42-8957-ce526087e5cd
Source feed: FDA_Inspections

> FDA Inspection 1193143 for Biomat USA, Inc. on December 02, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1193143
- Company Name: Biomat USA, Inc.
- Inspection Date: 2022-12-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1193143 - 2022-12-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4bb47888-c65c-4cdb-b4d2-946dc3addd0b)
- [FDA Inspection 1035427 - 2017-11-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/68081f62-92d4-464d-9ca6-4d2c079502f7)
- [FDA Inspection 975482 - 2016-05-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5589f872-52e2-429b-a46d-a3d6d603c367)

Company: https://www.keypedia.com/companies/biomat-usa-inc/cbbb264c-f000-4b4f-a49d-269b17369f1d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d